← Leaderboards
Martin C Darvas
University Of Washington
$3,115,484
Attributed
$7,128,651
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,128,651 · 2
By mechanism
R01$7,128,651 · 2
Top collaborators
- Warren C. Ladiges6 shared
- Cory Funk5 shared
- Christine Michelle Johnston5 shared
Most similar at University Of Washington
Same institution · by research overlap
- Warren C. Ladiges$25,544,366
- Matt Kaeberlein$21,041,861
- Jeffrey A Ranish$6,956,314
- Cory Funk$897,683
- Peter S Rabinovitch$49,936,459
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMouse ModelS Disease ModelPathologicBrainS DiseaseElderlyNeuropathologyInvestigationEventProteinsGenderMultidisciplinaryGene ExpressionDementiaPlayBaseLesionImpaired CognitionGeroscienceInfectionMorbidity - Disease RateAgingAnti Aging
Grant awards (11)
A geroscience approach for treating Alzheimer's disease$777,433
R01 · FY2024 · AG
A geroscience approach for treating Alzheimer's disease$777,433
R01 · FY2023 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$430,231
R01 · FY2023 · AG · contact PI
A geroscience approach for treating Alzheimer's disease$777,433
R01 · FY2022 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$513,438
R01 · FY2022 · AG · contact PI
A geroscience approach for treating Alzheimer's disease$777,433
R01 · FY2021 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$554,804
R01 · FY2021 · AG · contact PI
A geroscience approach for investigating resilience to SARS-CoV-2 pathology in mice with Alzheimer's disease$548,438
R01 · FY2021 · AG
A geroscience approach for treating Alzheimer's disease$777,433
R01 · FY2020 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$575,841
R01 · FY2020 · AG · contact PI
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$618,734
R01 · FY2019 · AG · contact PI